Morgan Stanley’s ProKidney PROK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.55M | Sell |
5,987,541
-4,349,682
| -42% | -$2.58M | ﹤0.01% | 4338 |
|
2025
Q1 | $9.06M | Sell |
10,337,223
-3,636,134
| -26% | -$3.19M | ﹤0.01% | 3430 |
|
2024
Q4 | $23.6M | Sell |
13,973,357
-297,028
| -2% | -$502K | ﹤0.01% | 2595 |
|
2024
Q3 | $27.4M | Sell |
14,270,385
-177,956
| -1% | -$342K | ﹤0.01% | 2473 |
|
2024
Q2 | $35.5M | Buy |
14,448,341
+4,121,663
| +40% | +$10.1M | ﹤0.01% | 2072 |
|
2024
Q1 | $16.9M | Sell |
10,326,678
-12,067,720
| -54% | -$19.8M | ﹤0.01% | 2873 |
|
2023
Q4 | $39.9M | Buy |
22,394,398
+12,108,032
| +118% | +$21.6M | ﹤0.01% | 2692 |
|
2023
Q3 | $47.1M | Buy |
10,286,366
+590,964
| +6% | +$2.71M | ﹤0.01% | 1637 |
|
2023
Q2 | $108M | Buy |
9,695,402
+84,317
| +0.9% | +$944K | 0.01% | 1038 |
|
2023
Q1 | $109M | Sell |
9,611,085
-1,336,410
| -12% | -$15.1M | 0.01% | 1010 |
|
2022
Q4 | $75.1M | Buy |
10,947,495
+595,839
| +6% | +$4.09M | 0.01% | 1210 |
|
2022
Q3 | $93.3M | Buy |
+10,351,656
| New | +$93.3M | 0.01% | 930 |
|
2022
Q1 | – | Sell |
-9,456
| Closed | -$94K | – | 8081 |
|
2021
Q4 | $94K | Buy |
9,456
+2,600
| +38% | +$25.8K | ﹤0.01% | 6484 |
|
2021
Q3 | $67K | Buy |
+6,856
| New | +$67K | ﹤0.01% | 6584 |
|